MedPath

Cetacaine Anesthetic

Cetacaine Topical Anesthetic Spray and Liquid

Approved
Approval ID

af1773c5-5d5b-4278-b551-30ad2df6d5b5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 17, 2022

Manufacturers
FDA

Cetylite Industries, Inc.

DUNS: 001283704

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Benzocaine, Butamben, and Tetracaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10223-0201
Product Classification
G
Generic Name
Benzocaine, Butamben, and Tetracaine Hydrochloride
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 17, 2022
FDA Product Classification

INGREDIENTS (7)

BenzocaineActive
Quantity: 0.028 g in 0.2 g
Code: U3RSY48JW5
Classification: ACTIB
ButambenActive
Quantity: 0.004 g in 0.2 g
Code: EFW857872Q
Classification: ACTIB
Mecetronium bromideInactive
Code: 7ZNQ7FIO9K
Classification: IACT
Tetracaine HydrochlorideActive
Quantity: 0.004 g in 0.2 g
Code: 5NF5D4OPCI
Classification: ACTIB
Dipropylene glycolInactive
Code: E107L85C40
Classification: IACT
SaccharinInactive
Code: FST467XS7D
Classification: IACT
Benzalkonium chlorideInactive
Code: F5UM2KM3W7
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cetacaine Anesthetic - FDA Drug Approval Details